12/1
08:30 am
lenz
LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia
Low
Report
LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia
11/25
04:56 pm
lenz
LENZ Therapeutics to Present at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
LENZ Therapeutics to Present at Upcoming Investor Conferences [Yahoo! Finance]
11/25
04:05 pm
lenz
LENZ Therapeutics to Present at Upcoming Investor Conferences
Low
Report
LENZ Therapeutics to Present at Upcoming Investor Conferences
11/22
07:57 am
lenz
LENZ Therapeutics (NASDAQ:LENZ) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
LENZ Therapeutics (NASDAQ:LENZ) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
11/12
05:45 am
lenz
Insider Spends US$239k Buying More Shares In LENZ Therapeutics [Yahoo! Finance]
Medium
Report
Insider Spends US$239k Buying More Shares In LENZ Therapeutics [Yahoo! Finance]
11/8
08:43 am
lenz
Analysts Are Upgrading LENZ Therapeutics, Inc. (NASDAQ:LENZ) After Its Latest Results [Yahoo! Finance]
Low
Report
Analysts Are Upgrading LENZ Therapeutics, Inc. (NASDAQ:LENZ) After Its Latest Results [Yahoo! Finance]
11/7
07:58 am
lenz
Growth Opportunities in the United States' $7+ Billion Ophthalmic Eye Droppers Market, 2025-2033 [Yahoo! Finance]
Low
Report
Growth Opportunities in the United States' $7+ Billion Ophthalmic Eye Droppers Market, 2025-2033 [Yahoo! Finance]
11/5
08:00 am
lenz
LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
High
Report
LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
11/5/2025
08:00 am
lenz
lenz therapeutics, inc.
BEAT
Report
-21.9%
lenz therapeutics, inc.
5/7/2025
04:05 pm
lenz
lenz therapeutics, inc.
BEAT
Report
2.1%
lenz therapeutics, inc.
3/19/2025
04:05 pm
lenz
lenz therapeutics, inc.
MISS
Report
6.7%
lenz therapeutics, inc.
3/19/2025
04:05 pm
lenz
lenz therapeutics, inc.
MISS
Report
6.7%
lenz therapeutics, inc.
Raymond James Financial, Inc.
11/19
07:02 pm
lenz
Form 4 LENZ Therapeutics, Inc. For: Nov 17 Filed by: Olsson Shawn
Medium
Report
Form 4 LENZ Therapeutics, Inc. For: Nov 17 Filed by: Olsson Shawn
11/17
04:38 pm
lenz
Form 144 LENZ Therapeutics, Inc. Filed by: Olsson Shawn
Medium
Report
Form 144 LENZ Therapeutics, Inc. Filed by: Olsson Shawn
11/14
04:39 pm
lenz
Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
Low
Report
Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
11/14
04:05 pm
lenz
Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Low
Report
Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
11/10
04:49 pm
lenz
Form SCHEDULE 13D/A LENZ Therapeutics, Inc. Filed by: Versant Venture Capital VI, L.P.
High
Report
Form SCHEDULE 13D/A LENZ Therapeutics, Inc. Filed by: Versant Venture Capital VI, L.P.
11/10
04:14 pm
lenz
Form 4 LENZ Therapeutics, Inc. For: Nov 07 Filed by: MCCOLLUM JAMES W
High
Report
Form 4 LENZ Therapeutics, Inc. For: Nov 07 Filed by: MCCOLLUM JAMES W
11/7
07:42 pm
lenz
Form 4 LENZ Therapeutics, Inc. For: Nov 07 Filed by: Chevallard Daniel R.
Low
Report
Form 4 LENZ Therapeutics, Inc. For: Nov 07 Filed by: Chevallard Daniel R.
11/7
04:47 pm
lenz
Form SCHEDULE 13D/A LENZ Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13D/A LENZ Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register